Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma
Authors:
Open Access
- 5 September 2016
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 51 (12) , 1609-1611
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stem cell mobilization in HIV seropositive patients with lymphomaHaematologica, 2013
- Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy ConsortiumLeukemia & Lymphoma, 2012
- HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)Transplantation and Cellular Therapy, 2010
- High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factorsBlood, 2009
- Autologous Stem-Cell Transplantation in Patients With HIV-Related LymphomaJournal of Clinical Oncology, 2009
- HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantationExperimental Hematology, 2005
- Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasBlood, 2005
- High-Dose Cytosine–Arabinoside and Cisplatin Regimens as Salvage Therapy for Refractory or Relapsed AIDS-Related Non-Hodgkin's LymphomaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993